HITIQ Limited
HITIQ Limited
Your view on HIQ.AX
Overview
What the company does, where it operates, and who runs it.
About HITIQ Limited
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Earl Robert Eddings
- Headquarters
- 38-42 White Street, Melbourne, VIC, AU
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Earl Robert Eddings
- Headquarters
- 38-42 White Street, Melbourne, VIC, AU
HITIQ Limited is an Australian enterprise focused on developing and commercializing advanced technology for concussion management. Its Nexus software platform delivers comprehensive data and analytical insights concerning head impacts, empowering informed decision-making to enhance care for athletes. The company also offers CoVR, a virtual reality-based system for assessing cognitive and oculomotor functions, capable of identifying impairments in areas such as hand-eye coordination, memory, and critical thinking. Additionally, CSX provides a straightforward sideline tool for concussion evaluation, generating digital records that can be easily shared with medical professionals, family members, and organizations to ensure coordinated athlete support. Established in 2015, the company maintains its headquarters in Melbourne, Australia.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for HITIQ Limited, and the rating behind it. HIQ.AX last traded at AUD 0.0080; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for HITIQ Limited. Starting points for HITIQ Limited: EPS -AUD 0.01, beta -0.63 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for HITIQ Limited. HITIQ Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for HITIQ Limited. Trailing twelve-month EPS for HITIQ Limited stands at -AUD 0.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for HITIQ Limited. HITIQ Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
HITIQ Limited valued side by side against its closest peers. HITIQ Limited is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold HITIQ Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by HITIQ Limited executives and directors. Shares of HITIQ Limited have traded between AUD 0.0040 and AUD 0.04 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming HITIQ Limited. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming HITIQ Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for HITIQ Limited. Coverage tracks HITIQ Limited within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.